These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 25565272)
21. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma. Maxwell JE; Gule-Monroe MK; Subbiah V; Hu M; Perrier ND; Cabanillas ME; Lee JE; Graham PH; Cote GJ; Busaidy NL; Grubbs EG Surgery; 2020 Jan; 167(1):80-86. PubMed ID: 31648931 [TBL] [Abstract][Full Text] [Related]
22. Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk. Barbieri RB; Bufalo NE; Cunha LL; Assumpção LV; Maciel RM; Cerutti JM; Ward LS Clin Endocrinol (Oxf); 2013 Aug; 79(2):288-93. PubMed ID: 23278115 [TBL] [Abstract][Full Text] [Related]
23. Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas. Pita JM; Figueiredo IF; Moura MM; Leite V; Cavaco BM J Clin Endocrinol Metab; 2014 Mar; 99(3):E497-507. PubMed ID: 24423316 [TBL] [Abstract][Full Text] [Related]
24. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
25. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514 [TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916 [TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? Baumgartner-Parzer SM; Lang R; Wagner L; Heinze G; Niederle B; Kaserer K; Waldhäusl W; Vierhapper H J Clin Endocrinol Metab; 2005 Nov; 90(11):6232-6. PubMed ID: 16118333 [TBL] [Abstract][Full Text] [Related]
28. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Mian C; Pennelli G; Barollo S; Cavedon E; Nacamulli D; Vianello F; Negro I; Pozza G; Boschin IM; Pelizzo MR; Rugge M; Mantero F; Girelli ME; Opocher G Eur J Endocrinol; 2011 Jun; 164(6):971-6. PubMed ID: 21422198 [TBL] [Abstract][Full Text] [Related]
29. Long-Term Follow-up in Medullary Thyroid Carcinoma. Raue F; Frank-Raue K Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391 [TBL] [Abstract][Full Text] [Related]
30. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels. Landa I; Montero-Conde C; Malanga D; De Gisi S; Pita G; Leandro-García LJ; Inglada-Pérez L; Letón R; De Marco C; Rodríguez-Antona C; Viglietto G; Robledo M Endocr Relat Cancer; 2010 Jun; 17(2):317-28. PubMed ID: 20075119 [TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the RET proto-oncogene and the phenotypic presentation of familial medullary thyroid carcinoma. Magalhães PK; de Castro M; Elias LL; Soares EG; Maciel LM Thyroid; 2004 Oct; 14(10):848-52. PubMed ID: 15588382 [TBL] [Abstract][Full Text] [Related]
34. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Goode EL; Fridley BL; Vierkant RA; Cunningham JM; Phelan CM; Anderson S; Rider DN; White KL; Pankratz VS; Song H; Hogdall E; Kjaer SK; Whittemore AS; DiCioccio R; Ramus SJ; Gayther SA; Schildkraut JM; Pharaoh PP; Sellers TA Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):935-44. PubMed ID: 19258477 [TBL] [Abstract][Full Text] [Related]
35. Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases. Beressi N; Campos JM; Beressi JP; Franc B; Niccoli-Sire P; Conte-Devolx B; Murat A; Caron P; Baldet L; Kraimps JL; Cohen R; Bigorgne JC; Chabre O; Lecomte P; Modigliani E Thyroid; 1998 Nov; 8(11):1039-44. PubMed ID: 9848720 [TBL] [Abstract][Full Text] [Related]
36. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320 [TBL] [Abstract][Full Text] [Related]
37. Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma. Guerrero IM; Pessoa CH; Olmedo DB; Pontes ER; Matos LC; Tilli TM; Barcinski MA; Gimba ER Thyroid; 2006 Jan; 16(1):9-15. PubMed ID: 16487008 [TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancer. Machens A; Frank-Raue K; Lorenz K; Rondot S; Raue F; Dralle H Clin Endocrinol (Oxf); 2012 May; 76(5):691-7. PubMed ID: 22111543 [TBL] [Abstract][Full Text] [Related]
39. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Driver KE; Song H; Lesueur F; Ahmed S; Barbosa-Morais NL; Tyrer JP; Ponder BA; Easton DF; Pharoah PD; Dunning AM; Carcinogenesis; 2008 Feb; 29(2):333-41. PubMed ID: 18174243 [TBL] [Abstract][Full Text] [Related]